1. Kawabata, A.*, Hayashi, T.*, Akasu-Nagayoshi, Y., Yamada, A., Shimizu, N., Yokota, N., Nakato, R.,Shirahige, K., Okamoto, A. & Akiyama, T. CRISPR/Cas9 Screening for Identification of Genes Required for the Growth of Ovarian Clear Cell Carcinoma Cells. Curr Issues Mol Biol. 44, 1587-1596(2022). doi:10.3390/cimb44040108. (*equal contribution)
2. Akasu-Nagayoshi, Y.*, Hayashi, T.*, Kawabata, A., Shimizu, N., Yamada, A., Yokota, N., Nakato, R.,Shirahige, K., Okamoto, A. & Akiyama, T. The phosphate exporter XPR1/SLC53A1 is required for the tumorigenicity of epithelial ovarian cancer. Cancer Sci. (2022). doi:10.1111/cas.15358. (*equal contribution)
3. Matsuura, K., Kobayashi, S., Konno, K., Yamasaki, M., Horiuchi, T., Senda, T., Hayashi, T., Satoh, K., Arima-Yoshida, F., Iwasaki, K., Negishi, L., Yasui-Shimizu, N., Kohu, K., Kawahara, S., Kirino, Y., Nakamura, T., Watanabe, M., Yamamoto, T., Manabe, T. & Akiyama, T. SIPA1L1/SPAR1 Interacts with the Neurabin Family of Proteins and is Involved in GPCR Signaling. J. Neurosci. 42, 2448-2473 (2022).
4. Cona, B., Hayashi, T., Yamada, A., Shimizu, N., Yokota, N., Nakato, R., Shirahige, K. & Akiyama, T. The splicing factor DHX38/PRP16 is required for ovarian clear cell carcinoma tumorigenesis, as revealed by a CRISPR-Cas9 screen. FEBS Open Bio 12, 582-593 (2022).
5. Morikawa, A., Kawabata, A., Shirahige, K., Akiyama, T., Okamoto, A. & Sutani, T. Altered cervicovaginal microbiota in premenopausal ovarian cancer patients. Gene 811, 146083 (2022).
6. Orikasa, S., Kawashima, N., Tazawa, K., Hashimoto, K., Sunada-Nara, K., Noda, S., Fujii, M., Akiyama, T. & Okiji, T. Hypoxia-inducible factor 1α induces osteo/odontoblast differentiation of human dental pulp stem cells via Wnt/β-catenin transcriptional cofactor BCL9. Sci. Rep. 12, 682 (2022).
7. Nakajima, N., Hayashi, T., Fujiki, K., Shirahige, K., Akiyama, T., Akutsu, T. & Nakato, R. Codependency and mutual exclusivity for gene community detection from sparse single-cell transcriptome data. Nucleic Acids Res. 49, e104 (2021).